Home › Funds › Cormorant Asset Management, LP › ABVX

Cormorant Asset Management, LP position in ABVX

ABIVAX SA · Health Care

Cormorant Asset Management, LP reported holding 675,000 shares of ABVX (ABIVAX SA) in its Q2 2026 13F filing — a position valued at US$90.0M, representing 4.61% of its reported portfolio and ranking #9 among its reported holdings. Cormorant Asset Management, LP has disclosed ABVX holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)675.00K sh
Reported value held$89.95M
Portfolio Weight4.61%
First reportedQ4 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Cormorant Asset Management, LP's ABVX position evolved

Cormorant Asset Management, LP first disclosed a stake in ABVX in Q4 2023 at 2,130,000 shares (US$22.8M). The position peaked in Q4 2025 at 1,350,000 shares, worth US$182.1M. Across 11 filings, Cormorant Asset Management, LP increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 675,000 shares valued at US$90.0M — a reduction of -85,000 shares quarter over quarter.. Notable position changes include a 31% trim in Q4 2025 (shares fell 17% over the following quarter), a 44% trim in Q1 2026 (shares rose 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 2.13M $22.79M New
Q1 2024 2.13M $30.46M Hold
Q2 2024 2.13M $28.16M Hold
Q3 2024 2.13M $24.54M Hold
Q4 2024 2.13M $15.59M Hold
Q1 2025 2.13M $13.31M Hold
Q2 2025 2.13M $16.29M Hold
Q3 2025 1.95M $165.56M Reduce
Q4 2025 1.35M $182.05M Reduce
Q1 2026 760.00K $84.63M Reduce
Q2 2026 675.00K $89.95M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABVX and 13F data

ABVX (ABIVAX SA) is a Health Care company. 72 other funds we track also report a position in ABVX — the largest reported positions include TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$371.4M), Darwin Global Management, Ltd. (US$348.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABVX

All ABVX fund holders →

FAQ

How long has Cormorant Asset Management, LP held ABVX?

Cormorant Asset Management, LP has disclosed ABVX holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is Cormorant Asset Management, LP's current position in ABVX?

As of Q2 2026, Cormorant Asset Management, LP holds 675.00K shares of ABVX (ABIVAX SA), valued at $89.95M, representing 4.61% of its reported portfolio and ranking #9.

Has Cormorant Asset Management, LP been buying or selling ABVX?

In the latest 13F filing (Q2 2026), Cormorant Asset Management, LP reduced its position in ABVX. The position peaked in Q4 2025 at 1.35M shares.

Which other funds hold ABVX?

Other major institutional holders of ABVX include TCG Crossover Management, LLC, Helikon Investments Ltd, Darwin Global Management, Ltd., among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.